Radicicol, a macrocyclic anti-fungal antibiotic, has the ability to suppress transformation by diverse oncogenes such as Src, Ras and Mos. Despite this useful property, the mechanism by which radicicol exerts its antitransformation eects is currently unknown. To understand the transformation-suppressing eects of radicicol, a biotinylated derivative of radicicol was chemically synthesized and used as a probe in a Western-blot format to visualize cellular proteins that interact with radicicol. In transformed and untransformed mouse ®broblasts, the most prominent cellular protein that bound to radicicol had a molecular weight of approximately 90 kDa. Further analysis revealed that this protein was the mouse homologue of the 90 kDa heat shock protein (HSP90). This was con®rmed by demonstrating the ability of radicicol to speci®cally bind puri®ed human HSP90. Speci®city of binding was demonstrated by the inhibition of binding of biotinylated radicicol by the native drug. Taken together with other studies the present observations suggest that the anti-transformation eects of radicicol may be mediated, at least in part, by the association of radicicol with HSP90 and the consequent dissociation of the Raf/HSP90 complex leading to the attenuation of the Ras/MAP kinase signal transduction pathway.
Radicicol, a macrocyclic anti-fungal antibiotic, has the ability to suppress transformation by diverse oncogenes such as Src, Ras and Mos. Despite this useful property, the mechanism by which radicicol exerts its antitransformation eects is currently unknown. To understand the transformation-suppressing eects of radicicol, a biotinylated derivative of radicicol was chemically synthesized and used as a probe in a Western-blot format to visualize cellular proteins that interact with radicicol. In transformed and untransformed mouse ®broblasts, the most prominent cellular protein that bound to radicicol had a molecular weight of approximately 90 kDa. Further analysis revealed that this protein was the mouse homologue of the 90 kDa heat shock protein (HSP90). This was con®rmed by demonstrating the ability of radicicol to speci®cally bind puri®ed human HSP90. Speci®city of binding was demonstrated by the inhibition of binding of biotinylated radicicol by the native drug. Taken together with other studies the present observa
Introduction
The mitogen-activated protein (MAP) kinase pathway serves as one of the principal conduits for transmission of signals generated by extracellular mitogenic growth factors (reviewed in Marshall, 1994; Robinson and Cobb, 1997) . Oncogenes, or cancer causing genes, frequently subvert signal transduction pathways utilized by growth factors (reviewed in Hunter, 1997) . In particular, oncogenes such as Raf, Mos and the recently discovered oncogene Tpl2 (Salmeron et al., 1996) have been implicated in directly hyper-activating the MAP kinase pathway and this seems to be, in part, responsible for their transforming capabilities (reviewed in Hunter, 1997; Marais and Marshall, 1996) . The Ras oncogene also activates the MAP kinase pathway, albeit indirectly, via its down-stream eector, Raf (reviewed in Avruch et al., 1994; Morrison and Cutler, 1997) . The importance of Raf in mediating the oncogenic eects of Ras is well documented (Leevers et al., 1994; Moodie et al., 1993; Vanaelst et al., 1993; Vojtek et al., 1993; Warne et al., 1993; reviewed in Marshall, 1995b) , although other studies suggest that additional, Raf-independent events are also important in Ras-mediated transformation (Khosravi-Far et al., 1996 ; reviewed in Katz and McCormick, 1997) . Besides Ras, other proteins that interact with Raf, and perhaps regulate it, include Mitogen-or extracellular-regulated kinase (MEK1/2); proteins of the 14-3-3 family; molecular chaperones such as HSP90 and Cdc37/p50; and the protein Kinase Suppressor of Ras (KSR) (reviewed in Morrison and Cutler, 1997) . Interaction of HSP90 and Cdc37/p50 appears to be important for the proper intracellular localization and stability of Raf (Schulte et al., 1995 (Schulte et al., , 1996 Stancato et al., 1997; reviewed in Hunter and Poon, 1997) .
Members of the Ras family, as well as proteins that regulate them, are particularly important with respect to human cancer, since they are frequently deregulated in human tumors (reviewed in Hunter, 1997) . Given the central role of Ras oncogenes in human cancer, much eort has been devoted to the identi®cation of agents that are capable of suppressing its oncogenic capabilities (reviewed in Oli et al., 1996) . One fruitful approach has utilized the detailed information available regarding the Ras oncoprotein and exploited the requirement for membrane association of Ras for its activity (reviewed in Gibbs et al., 1996; Koblan et al., 1996) . Other approaches target the Ras signal transduction pathway as a means to control its activity (reviewed in Marshall, 1995a ). An example of an agent that suppresses Rastransformation by the latter approach, is radicicol (Kwon et al., 1995; Soga et al., 1998; Zhao et al., 1995) . In addition to Ras-transformed cells, radicicol also suppresses the transformed phenotype of cells expressing activated Src (Kwon et al., 1992b) and Mos oncogenes (Zhao et al., 1995) . In both Ras-and Mostransformed cells radicicol treatment led to the generalized attenuation of the Ras-Raf-MAP kinase pathway in vivo (Zhao et al., 1995) , but had no eects on the kinase activity of MAP kinase kinase (MAPKK) or MAP kinase in vitro (Kwon et al., 1995) . This apparent paradox adds to the conundrum of the mechanism of transformation suppression by radicicol. Attempts to unravel the mechanism of action of radicicol have revealed that radicicol treatment of Ras transformed cells leads to a destabilization of the Raf-1 protein (Soga et al., 1998) and consequently inhibition of MAPK activity. Although this ®nding explains how radicicol can inhibit MAPK in vivo, but not in vitro, it still leaves unresolved the mechanism of Raf-1 destabilization by radicicol.
The present studies demonstrate the ability of radicicol to directly associate with murine and human HSP90 in a highly selective and speci®c manner. These ®ndings suggest the possibility that radicicol, by binding to HSP90, may destabilize the Raf-1-HSP90 complex in a manner reminiscent of the benzoquinone ansamycin, geldanamycin (Schulte et al., 1996) . In this regard, radicicol is the ®rst non-ansamycin antibiotic to associate speci®cally with HSP90.
Results
Generation and use of a biotinylated derivative of radicicol to identify radicicol binding cellular proteins
The ability of radicicol to suppress transformation by a diverse array of oncogenes suggested the possibility that intracellular targets of radicicol may lie at the intersection of dierent pathways utilized by various oncogenes. Therefore, identi®cation of cellular proteins that radicicol binds speci®cally may point to key intracellular targets, which may be valuable candidates for chemotherapeutic intervention. With this goal in mind, a biotinylated derivative of radicicol was synthesized. The structure of radicicol (shown in Figure 1b ) contains an epoxide residue that is critical for its antifungal properties (Ayer et al., 1980) and may play a role in its biological activity as a tyrosine kinase inhibitor (Kwon et al., 1992a) . In addition, radicicol, like many other tyrosine kinase inhibitors, possesses phenolic ring structures that may be necessary for its function. With these constraints in mind, the biotin group was attached to radicicol, at C9, via an oxime linkage, using a 12 carbon spacer arm (Figure 1a ). Biotinylated radicicol (KT8529) was used in a Western-blot format, in which total cellular proteins were immobilized on nitrocellulose membranes and probed with KT8529, followed by Streptavidin-Horse Radish Peroxidase (HRP). The , were electrophoresed on a 5% polyacrylamide gel, transferred to nitrocellulose membranes and probed with either 2.6 mg/ml of UCS1006 (lanes 1 ± 4), 1.3 mg/ml of KT8529 (lanes 6 ± 9) or ®rst with 2.6 mg/ml of UCS1006 followed by 1.3 mg/ml of KT8529 (lanes 11 ± 14) as indicated at the bottom of the autoradiograms. Biotinylated protein bands were detected by incubating the ®lters with streptavidin-HRP and visualized by chemiluminescence (for details see Experimental procedures). For reference pre-stained molecular weight markers (high range from BioRad) were used and their approximate positions are indicated on either side of the ®gure. They are in descending order of size: 115 000 daltons (bgalactosidase), 89 000 daltons (bovine serum albumin) and 52 000 daltons (ovalbumin). The position of the 90 kDa protein is indicated by an asterisk in lanes 5 and 10 presence of proteins bound to radicicol were detected by chemiluminescence ( Figure 1c ). KT8529 was capable of binding a doublet of proteins of about 90 kDa in cell lysates prepared from SRC-3T3 cells ( Figure 1c , lanes 6 ± 9; position demarcated by an asterisk). That these proteins were speci®cally recognized by radicicol was demonstrated by the fact that pre-treatment of the ®lters with native radicicol (UCS1006) eectively abolished the binding of KT8529 to these proteins ( Figure 1c , lanes 11 ± 14). Figure 1c , lanes 1 ± 4 demonstrate that despite the exquisite speci®city of Streptavidin for biotin, cell lysates contain proteins that bind to Streptavidin. These represent the background noise in this system and was the rationale for pre-clearing the lysates with two rounds of Streptavidin-Agarose prior to Westernblot analysis (for details see Experimental procedures). These results suggest that KT8529 can be used quite eectively to detect cellular proteins that bind radicicol and validate the Western-blot system as a convenient means to examine such proteins.
The 90 kDa radicicol binding protein(s) is present in Ras-and Src-transformed cells and co-migrates with puri®ed human HSP90
Previous studies have shown that HSP90 was required for the stabilization and appropriate intracellular localization of Raf (Schulte et al., 1995 (Schulte et al., , 1996 . The observations of (Soga et al., 1998) suggested that radicicol treatment of K-Ras transformed cells resulted in the destabilization of Raf-1. These data, together with the observation that radicicol bound speci®cally to a 90 kDa doublet in total cell extracts ( Figure 1c ), suggested the possibility that the 90 kDa radicicolbinding protein(s) may be the mouse homologue of HSP90. To further explore this possibility, cell lysates from Src-and Ras-transformed cells were electrophoresed alongside puri®ed preparations of human HSP90, electroblotted to nitrocellulose membranes and probed with KT8529 ( Figure 2 ). Radicicol-binding protein(s) of approximately 90 kDa were detected in Rastransformed ( Figure 2 , lanes 1 ± 4) and Src-transformed ( Figure 2 , lanes 11 ± 14) cell lysates. Previous studies have shown that HSP90 exists as two isoforms encoded by separate genes and referred to as HSP84/ HSP86 in murine cells (Moore et al., 1990) and HSP90a/HSP90b in human cells (Rebbe et al., 1989) . In this and subsequent experiments the gel system did not resolve the 84/86 kDa band into a doublet as seen in Figure 1c (lanes 6 ± 9). Therefore, the protein(s) though a doublet will be referred to as the 90 kDa protein. Furthermore, radicicol bound puri®ed human HSP90 (Figure 2 , lanes 5, 6, 9, 10), which co-migrated with the 90 kDa radicicol-binding protein present in cell-lysates. In Src-transformed cell lysates, the additional bands are part of the background seen also in Figure 1c . Similar results were obtained when untransformed NIH3T3 lysates were used (data not shown). These results suggested that radicicol bound to a 90 kDa protein that was present in untransformed, as well as Ras-and Src-transformed cells. This 90 kDa radicicolbinding protein co-migrated with puri®ed human HSP90, suggesting the possibility that the two proteins are related, if not identical.
Speci®city of radicicol binding to the 90 kDa protein and to puri®ed human HSP90
Previous results strongly suggested that radicicol bound to a 90 kDa cellular protein (Figure 1c ) that comigrated with human HSP90 (Figure 2) . To examine the speci®city of this interaction, the ability of native radicicol to block binding of KT8529 to the 90 kDa protein was examined (Figure 3 ). To this end, cell lysates from Ras-transformed mouse ®broblasts, as well as puri®ed human HSP90, were electrophoretically separated and transferred to nitrocellulose membranes. One set of samples was probed with KT8529 ( Figure  3a , lanes 1 ± 6) and an identical set of samples was ®rst incubated with native radicicol (to block the radicicol binding sites) and subsequently probed with KT8529 ( Figure 3a , lanes 9 ± 14). As before, KT8529 recognized a 90 kDa protein in cell lysates from Ras-transformed NIH3T3 cells (Figure 3a , lanes 1 ± 4). This 90 kDa radicicol-binding protein co-migrated with puri®ed human HSP90 which was also recognized by KT8529 (Figure 3a , lanes 5 and 6). Speci®city of radicicol binding was demonstrated by the blocking of binding of KT8529 by pre-incubation of the nitrocellulose membrane with UCS1006 (native radicicol) (Figure 3a , lanes 9 ± 14). Similar experiments with increasing amounts of puri®ed human HSP90 very conclusively demonstrated that the interaction of radicicol with human HSP90 was also very highly speci®c (Figure ). The faint, 90 kDa band seen in lanes 8 and 9 is probably due to incomplete blocking of HSP90 by radicicol and results, very likely, from the abundance of HSP90 present in the lanes (4 and 8 mgs; compare lanes 3, 4 and 8, 9). The identity of the higher molecular weight cross-reacting band (around 120 kDa in Figure 3b , lanes 8 and 9) is unknown. These results indicated that the binding of radicicol to the 90 kDa cellular protein, as well as human HSP90, was speci®c and strongly suggested the possibility that the two proteins were one and the same.
The 90 kDa radicicol-binding protein and HSP90 are one and the same Despite the previous results suggesting the similarity between the 90 kDa radicicol-binding protein and HSP90, a remote possibility existed that the comigration and radicicol binding of the two proteins may be a fortuitous coincidence. To further investigate the similarity between the 90 kDa radicicol-binding protein and HSP90, antibody speci®c for the HSP90 (AC88) was used in parallel analyses with KT8529 ( Figure 4 ). As shown in the previous sections, KT8529 bound to a 90 kDa cellular protein from Rastransformed cells that co-migrated with human HSP90, which also bound KT8529 (Figure 4 , lanes 1 ± 6). That this protein was HSP90, was further con®rmed by probing ®lters containing similar samples, with the anti-HSP90 monoclonal antibody (Figure 4 , lanes 8 ± 13). The monoclonal antibody cross-reacted with a large number of cellular proteins at least one of which has previously been shown to be the 95 kDa mouse glucocorticoid receptor. In addition, this experiment shows the large number of proteins ( were separated by electrophoresis on a 7.5% polyacrylamide gel, transferred to nitrocellulose membranes and probed with either KT8529 (lanes 1 ± 6) or ®rst with UCS1006 followed by KT8529 (lanes 9 ± 14) as indicated at the bottom of the autoradiograms and as described in the legend to Figure 1c. (b) Dierent amounts of puri®ed human HSP90 (as indicated at the top of each lane), were separated by electrophoresis on a 7.5% polyacrylamide gel, transferred to nitrocellulose membranes and probed with either KT8529 (lanes 1 ± 4) or ®rst with UCS1006 followed by KT8529 (lanes 6 ± 9) as indicated at the bottom of the autoradiograms and as described in the legend to 
Radicicol and Geldanamycin do not bind to identical sites on HSP90
To date, only ansamycin benzoquinones such as herbimycin and geldanamycin have been shown to bind speci®cally to HSP90 and recently the molecular details of this binding have been elucidated (Grenert et al., 1997; Prodromou et al., 1997a,b; Stebbins et al., 1997) . The ability of radicicol to bind to HSP90 and cause the destabilization of Raf (Soga et al., 1998 ) is reminiscent of geldanamycin Schulte et al., 1995 Schulte et al., , 1996 Stancato et al., 1997) . To compare the HSP90 binding ability of radicicol and geldanamycin, the ability of geldanamycin to block the speci®c binding of radicicol to HSP90 was examined ( Figure  5 ). To this end, cell lysates from Ras-and Srctransformed NIH3T3 cells (Figure 5a and b respectively), were electrophoretically separated and transferred to nitrocellulose membranes. Filters containing dierent amounts of cell lysates were probed with KT8529 ( Figure 5a and b, lanes 1 ± 4). An identical set of samples was ®rst incubated with either geldanamycin (30 mM) followed by KT8529 (Figure 5a and b, lanes 6 ± 9), or native radicicol (to block the radicicol binding sites) followed by KT8529 (Figure 5a and b, lanes 11 ± 14). As before, KT8529 recognized a 90 kDa protein in cell lysates from Ras-and Src-transformed NIH3T3 cells (Figure 5a and b, lanes 1 ± 4) . This 90 kDa radicicol-binding protein co-migrated with puri®ed human HSP90 which was also recognized by KT8529 (Figure 5a and b, lane 4) . Also, binding of biotinylated radicicol was speci®cally blocked by native radicicol (Figure 5a and b, lanes 11 ± 14) . However, pre-incubating the ®lters with geldanamycin had little or no eect on the binding of radicicol to HSP90 (Figure 5a and b, lanes 6 ± 9). These results suggest that geldanamycin does not interfere with the binding of radicicol to HSP90 and raise the possibility that the two drugs may bind to distinct sites. This is not altogether unexpected, given the very dierent chemical structures of the two agents.
Discussion
Previous studies have documented that radicicol has the capacity to suppress transformation by a variety of oncogenes such as Src, Ras and Mos (Kwon et al., 1992b (Kwon et al., , 1995 Zhao et al., 1995) . However, the molecular mechanism of action of radicicol is currently unknown. The present studies identify HSP90 as a radicicol-binding protein and suggest some interesting mechanistic possibilities for transformation suppression by radicicol. These observations are especially germane in light of recent ®ndings that radicicol treatment of K-Ras transformed cells leads to the selective degradation of Raf-1 and a concomitant suppression of the transformed phenotype (Soga et al., 1998) . In addition, previous studies have shown that radicicol treatment attenuates the MAP kinase pathway in vivo (Zhao et al., 1995) , but has little or no eect on the in vitro activity of MAP kinase (Kwon et al., 1995) . In its inactive state Raf exists as a cytosolic multi-protein complex, associated with proteins such as HSP90, Cdc37/p50 and 14-3-3. Mitogen stimulation and/or Ras-transformation, results in the Ras-mediated recruitment of the cytosolic complex to the plasma membrane, where it acquires additional proteins such as KSR and Ras and results in a membrane bound multi-protein signaling complex (reviewed in Morrison and Cutler, 1997) . Molecular chaperones such as HSP90 play a major role in cellular homeostasis by aiding in the proper folding and localization of a number of key proteins (reviewed in Johnson and Craig, 1997) . The association of Raf-1 with the molecular chaperones HSP90 and cdc37/p50 appears to play a critical role in maintaining the stability and membrane localization of Raf (Schulte et al., 1995 (Schulte et al., , 1996 . In particular, HSP90 binding agents such as the benzoquinone ansamycin, geldanamycin, promotes ± 4) , pre-incubated ®rst with geldanamycin followed by KT8529 (lanes 6 ± 9) or pre-incubated ®rst with UCS1006 followed by KT8529 (lanes 11 ± 14) as indicated at the bottom of the autoradiograms and as described in the Materials and methods section. The position of HSP90 is indicated by arrows in lanes 5 and 10. (b) Identical experiment to the one in Figure 5a , except that the lysates were from SRC-3T3 cells active degradation of Raf and reduces signaling through the Raf-MAP kinase pathway Schulte et al., 1995 Schulte et al., , 1996 Stancato et al., 1997) . In addition to Raf, geldanamycin appears capable of eecting the depletion of other growth-regulatory signaling proteins, as well as nuclear hormone receptors, a property that is generally believed to be responsible for its anti-neoplastic activity (Stebbins et al., 1997, and references therein) . The present studies add radicicol to the list of HSP90 binding drugs and suggest the possibility that, like geldanamycin, radicicol may be promoting the destabilization of Raf through its interaction with HSP90. This could, at least in part, explain the ability of radicicol to suppress Rastransformation. Destabilization of Raf cannot, however, explain how radicicol mediates suppression of Src-transformation, since Src is not believed to exert its eects via the Raf-MAP kinase pathway (reviewed in Hunter, 1997) . However, the present observation that radicicol binds HSP90 may also provide the mechanistic basis for the suppression of Src-transformation by radicicol, since HSP90 appears to play a critical role in the cellular tracking and proper localization of Src to the plasma membrane (Mimnaugh et al., 1995) . In this regard, it is interesting to note that the HSP90 binding drug, geldanamycin, is also capable of reverting the transformed phenotype of Src-transformed cells (Whitesell et al., 1994) , as well as cells transformed by other members of the Src-family of tyrosine kinases, such as lck (Hartson et al., 1996) . However, unlike the situation with Raf, geldanamycin does not promote the degradation of Src (Whitesell et al., 1994) . This dierence may be due to the fact that, whereas only a small fraction of Src interacts transiently with HSP90 immediately following translation (Oppermann et al., 1981) , Raf is constitutively associated with HSP90 (Wartmann and Davis, 1994) . Moreover, Src associated with HSP90 is inactive as a kinase (Brugge, 1986) , whereas the active form of Raf is associated with HSP90 (Schulte et al., 1995 (Schulte et al., , 1996 . These dierences may re¯ect the intrinsically dierent roles that HSP90 plays in regulating the activity of Src and Raf. Association of radicicol with HSP90, in Src-transformed cells, may hinder the HSP90-mediated folding and/or localization of Src and consequently interfere with its transforming capability.
Despite the similarities between geldanamycin and radicicol, i.e. HSP90 binding, destabilization of Raf and the fact that both drugs possess a macrocyclic moiety, the two drugs are structurally very dissimilar. Recently, the crystal structure of HSP90-geldanamycin complex has been resolved and reveals that geldanamycin binds inside a 15 A Ê , ATP/ADP binding pocket, in the N-terminal region of HSP90, that serves to regulate the conformation of HSP90 (Grenert et al., 1997; Prodromou et al., 1997a; Stebbins et al., 1997) . It is likely that geldanamycin blocks the access of ATP/ ADP and interferes with the association of HSP90 with its natural substrates (proteins such as Raf, that are undergoing conformational maturation) thus resulting in the turn-over of malfolded Raf. One tantalizing possibility is that radicicol may accelerate the degradation of Raf by a similar mechanism. However, preliminary studies ( Figure 5 ) suggests that the two drugs bind to distinct sites. It would, therefore, be very interesting to further characterize the region of HSP90 that radicicol binds to. Regardless of the molecular details, the present studies, together with the studies of (Soga et al., 1998) , strongly suggest that radicicol binding to HSP90 may play a role in the antitransformation properties of this drug. However, it is also possible that other, more relevant intracellular targets of radicicol may be critical for its transformation suppression capabilities. The identi®cation and analysis of such targets should be possible using approaches similar to the one described in the present study. In this regard, this study also serves to demonstrate`proof of principle' and validates this approach in the identi®cation of novel targets of radicicol.
Materials and methods
Cell lines, antibodies, drugs and reagents NIH3T3, RAS-3T3 and SRC-3T3 cells were maintained as described previously (Sharma et al., 1997) . Mouse monoclonal antibody speci®c for human HSP90 (AC88, from StressGen Biotech. Corp.), puri®ed human HSP90 protein (StressGen Biotech. Corp.), Streptavidin Agarose (Upstate Biotech. Inc.), Streptavidin conjugated to HRP (Zymed), Goat Anti-mouse Immunoglobulins conjugated to HRP (BioRad), were used according to speci®cations provided by the suppliers. Radicicol (UCS1006) and Biotinylated radicicol (KT8529) were chemically synthesized at Kyowa Hakko Kogyo Co. Pvt. Ltd., Tokyo Research Labs., Tokyo, Japan. Geldanamycin was kindly provided by Dr Len Neckers (NCI, NIH, Bethesda, MD).
Preparation of lysates
Plates of 2 day old sub-con¯uent cells (NIH3T3, RAS-3T3, SRC-3T3) were washed once with ice cold phosphate buered saline (PBS) (containing 0.1 mM sodium orthovanadate). Cells were then lysed by the addition to the plate of 1.5 ml of RIPA buer containing 50 mM TRIS, pH 8.0; 150 mM sodium chloride; 1% Triton X-100; 1% sodium deoxycholate; 0.1% sodium dodecyl sulfate; 0.2% sodium azide; 1 mM sodium orthovanadate; 10 mg/ml leupeptin; 10 mg/ml aprotinin; 5 mM phenyl methyl sulfonyl¯uoride. Samples were placed on ice for 10 min after which the lysates were collected and clari®ed by centrifugation at 16 000 g for 30 min at 48C. Lysates were pre-cleared with two rounds of Streptavidin-Agarose (200 ml of 50% solution) over a 12 h period at 48C. Clari®ed samples were collected by centrifugation and stored at 7208C. Lysates were not subjected to more than three freeze-thaw cycles. Puri®ed human HSP90 was resuspended in 16 Laemmli's sample buer and stored at 7208C.
Electrophoresis and immunoblotting
Total protein samples were resuspended in an equal volume of 26 Laemmli sample buer, and separated by electrophoresis on 7.5% sodium dodecyl sulfate-polyacrylamide gels (SDS ± PAGE) (Laemmli, 1970) . In some experiments, where puri®ed human HSP90 was used, the protein was processed identically to total cell lysates. Electrophoretically separated proteins were transferred to PVDF membranes (Amersham) and the non-speci®c protein binding sites were blocked by incubating the ®lters with PBS containing 3% bovine serum albumin (BSA) and 0.2% Tween (blocking solution). Filters were subsequently probed with KT8529 (3 mM) or anti-HSP90 antibody (1 : 500 dilution) in blocking solution (90 min at room temperature). In some cases the ®lters were preincubated with UCS1006 (30 mM) or geldanamycin (30 mM). Filters were then washed brie¯y, twice (5 min at room temperature), with PBS containing 0.2% Tween (wash buer). Subsequently, the ®lters were incubated with either Streptavidin-HRP (1 : 4000) or HRP conjugated Goat antimouse immunoglobulins in blocking solution (60 min at room temperature) and visualized by chemiluminescence (ECL detection kit, Amersham) as described (Zhao et al., 1995) .
Note added in Proof
The binding of radicicol to HSP90 has also been independently demonstrated. These studies are decribed in: Schulte TW, Akinaga S, Soga S, Sullivan W, Stensgard B, Toft D and Neckers LM. (1998) . The antibiotic radicicol binds to the N-terminal domain of HSP90 and shares important biologic activities with Geldanamycin. Cell Stress and Chaperones. (In press).
